PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences

被引:53
作者
Thobois, S
Jahanshahi, M
Pinto, S
Frackowiak, R
Limousin-Dowsey, P
机构
[1] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England
[2] Inst Neurol, Funct Imaging Lab, London WC1N 3BG, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Parkinson; PET; SPECT; deep brain stimulation;
D O I
10.1016/j.neuroimage.2004.04.039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Functional imaging techniques provide major insights into understanding the pathophysiology, progression, complications, and differential diagnosis of Parkinson's disease (PD). The dopaminergic system has been particularly studied allowing now early, presymptomatic diagnoses, which is of interest for future neuroprotective strategies. The existence of a compensatory hyperactivity of dopa-decarboxylase at disease onset has been recently demonstrated in the nigrostriatal and also extrastriatal dopaminergic pathways. Modification of dopamine receptors expression is observed during PD, but the respective contribution of dopaminergic drugs and the disease process towards these changes is still debated. Abnormalities of cerebral activation are seen and are clearly task-dependent, but the coexistence of hypoactivation in some areas and hyperactivation in others is also now well established. Such hyperactivation may be compensatory but could also reflect an inability to select appropriate motor circuits and inhibit inappropriate ones by PD patients. Interestingly, dopaminergic medications or surgical therapy reverse such abnormalities of brain activation. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 210 条
[1]   [C-11] RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSONS-DISEASE - INFLUENCE OF L-DOPA AND LISURIDE THERAPY ON STRIATAL DOPAMINE D-2-RECEPTORS [J].
ANTONINI, A ;
SCHWARZ, J ;
OERTEL, WH ;
BEER, HF ;
MADEJA, UD ;
LEENDERS, KL .
NEUROLOGY, 1994, 44 (07) :1325-1329
[2]   Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease [J].
Antonini, A ;
Leenders, KL ;
Vontobel, P ;
Maguire, RP ;
Missimer, J ;
Psylla, M ;
Günther, I .
BRAIN, 1997, 120 :2187-2195
[3]   The metabolic anatomy of tremor in Parkinson's disease [J].
Antonini, A ;
Moeller, JR ;
Nakamura, T ;
Spetsieris, P ;
Dhawan, V ;
Eidelberg, D .
NEUROLOGY, 1998, 51 (03) :803-810
[4]  
Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO
[5]  
2-Z
[6]   Hallucinations, REM sleep, and Parkinson's disease - A medical hypothesis [J].
Arnulf, I ;
Bonnet, AM ;
Damier, P ;
Bejjani, BP ;
Seilhean, D ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2000, 55 (02) :281-288
[7]  
BANATI R, 2000, MOV DISORD S3, V15, pP1015
[8]   LOSS OF STRIATAL [BR-76] BROMOSPIPERONE BINDING-SITES DEMONSTRATED BY POSITRON TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY [J].
BARON, JC ;
MAZIERE, B ;
LOCH, C ;
CAMBON, H ;
SGOUROPOULOS, P ;
BONNET, AM ;
AGID, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) :131-136
[9]   IMAGING OF HUMAN-BRAIN LESIONS WITH AN OMEGA-3 SITE RADIOLIGAND [J].
BENAVIDES, J ;
CORNU, P ;
DENNIS, T ;
DUBOIS, A ;
HAUW, JJ ;
MACKENZIE, ET ;
SAZDOVITCH, V ;
SCATTON, B .
ANNALS OF NEUROLOGY, 1988, 24 (06) :708-712
[10]   Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET [J].
Berding, G ;
Odin, P ;
Brooks, DJ ;
Nikkhah, G ;
Matthies, C ;
Peschel, T ;
Shing, M ;
Kolbe, H ;
van den Hoff, J ;
Fricke, H ;
Dengler, R ;
Samii, M ;
Knapp, WH .
MOVEMENT DISORDERS, 2001, 16 (06) :1014-1022